Name: ICD-9-CM Coordination and Maintenance Committee meeting.
Time and Date: 9 a.m.-4:30 p.m., September 15-16, 2010.
Place: Centers for Medicare and Medicaid Services (CMS) Auditorium, 7500 Security Boulevard, Baltimore, Maryland.
Status: Open to the public.
Purpose: The ICD-9-CM Coordination and Maintenance (C&M) Committee will hold its second meeting of the 2010 calendar year cycle on Wednesday and Thursday September 15-16, 2010. The C&M meeting is a public forum for the presentation of proposed modifications to the International Classification of Diseases, Ninth-Revision, Clinical Modification.
Matters To Be Discussed
Section 10109(c) of the Patient Protection and Affordable Care Act and the Reconciliation Act of 2010 (PPACA) requires the Secretary of Health and Human Services (HHS) to task the C&M Committee to convene a meeting before January 1, 2011, to receive stakeholder input regarding the crosswalk between the Ninth and Tenth Revisions of the International Classification of Diseases (ICD-9, and ICD-10, respectively), posted to the CMS Web site at http://www.cms.gov/ICD10, for the purpose of making appropriate revisions to said crosswalk. Section 10109(c) further states that any revised crosswalk be treated as a code set for which a standard has been adopted by the Secretary, and that revisions to this crosswalk be posted to the CMS Web site.
The C&M Committee will use the first half of the first day of the September C&M Committee meeting, 9 a.m. to 12:30 p.m. Wednesday, September 15, 2010, to fulfill the above-referenced PPACA requirements for this meeting to be held prior to January 1, 2011, and receive public input regarding the above-referenced crosswalk revision. No other meeting will be convened by the C&M Committee for this purpose. Interested parties and stakeholders should be prepared to submit their written comments and other relevant documentation at the meeting, or no later than November 12, 2010 to the following addresses:
Pat Brooks, RHIA, Senior Technical Advisor, Centers for Medicare & Medical Services, Hospital and Ambulatory Policy Group, Mail Stop C4-08-06, 7500 Security Boulevard, Baltimore, MD 21244-1850. Patricia.email@example.com.
Donna Pickett, RHIA, MPH, Medical Systems Administrator, National Center for Health Statistics, Centers for Disease Control and Prevention, Classifications and Public Health Data Standards, 3311 Toledo Road, Room 2337, Hyattsville, MD 20782. DPickett@cdc.gov.
Additional Information: Additional information regarding the tentative diagnosis and procedures topics will be published in a separate notice one month prior to the meeting.
Notice: Because of increased security requirements CMS has instituted stringent procedures for entrance into the building by non-government employees. Persons without a government I.D. will need to show an official form of picture I.D., (such as a drivers license), and sign-in at the security desk upon entering the building.
Those who wish to attend a specific ICD-9-CM C&M meeting in the CMS auditorium must submit their name and organization for addition to the meeting visitor list. Those wishing to attend the September 15-16, 2010 meeting must submit their name and organization by September 10, 2010 for inclusion on the visitor list. This visitor list will be maintained at the front desk of the CMS building and used by the guards to admit visitors to the meeting. Those who attended previous ICD-9-CM C&M meetings will no longer be automatically added to the visitor list. You must request inclusion of your name prior to each meeting you attend. Register to attend the meeting on-line at: http://www.cms.hhs.gov/apps/events/.
Notice: This is a public meeting, however, due to fire code requirements seating may be limited.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.Start Signature
Dated: June 30, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2010-16610 Filed 7-7-10; 8:45 am]
BILLING CODE 4160-18-P